Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dwight Moxie Insider Profile
4 Followers
Dwight Moxie, CLO & GC at Revance Therapeutics, holds 137.81K shares in Revance Therapeutics (Ticker: RVNC). Most recently, Dwight Moxie Sold $11,394 shares of Revance Therapeutics on Mar 19, 2024 for an estimated value of 58.28K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+65.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
CLO & GC
Roles that Dwight Moxie holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 16, 2023 - May 16, 2024
Return:+90.50%
The most profitable trade made by Dwight Moxie
Dwight Moxie's Trading History
List of latest transactions for each holding click on a transaction to see Dwight Moxie's performance on stock
You May Also Like
Dwight Moxie insider profile FAQ
What is the percentage of profitable transactions made by Dwight Moxie?
The percentage of profitable transactions made by Dwight Moxie is 100%.
What is the average return per transaction made by Dwight Moxie?
The average return per transaction made by Dwight Moxie is 65.30%.
What stocks does Dwight Moxie hold?
Dwight Moxie holds: RVNC stocks.
What was Dwight Moxie’s latest transaction?
Dwight Moxie latest transaction was an Informative Sell of $58.28K.
What was Dwight Moxie's most profitable transaction?
Dwight Moxie’s most profitable transaction was an Informative Sell of RVNC stock on May 16, 2023. The return on the trade was 90.50%.
What is Dwight Moxie's role in Revance Therapeutics?
Dwight Moxie's role in Revance Therapeutics is CLO & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.